about
New antivirals for the treatment of chronic hepatitis B.A Role for the Host DNA Damage Response in Hepatitis B Virus cccDNA Formation-and Beyond?Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication.[Personalized treatment of viral hepatitis of the present and the future : Hepatitis B, C, delta, and E].An Overview of Hepatitis B Virus Surface Antigen Secretion Inhibitors.Research gaps in viral hepatitis.Tim-3 blockade promotes iNKT cell function to inhibit HBV replication.
P2860
Q39315990-E04E4050-9D59-4258-9BE1-2EE27812525EQ39322379-EDAA85DF-C270-46AB-BA5A-2A0AD8E13D6DQ40054837-C1C371A5-EE86-47C3-9FF8-6393AA609FECQ40153413-9B278469-68C2-48C3-AAF9-CF7CE83AC8AAQ52576104-0D412266-783D-415E-AB1C-D1F902402773Q52597010-C139A79D-1B5E-46F3-89D5-EC59BE8067F2Q54965814-2410E72D-B858-4CC0-92BB-6B14BF53D0F9
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Novel targets for hepatitis B virus therapy.
@en
Novel targets for hepatitis B virus therapy.
@nl
type
label
Novel targets for hepatitis B virus therapy.
@en
Novel targets for hepatitis B virus therapy.
@nl
prefLabel
Novel targets for hepatitis B virus therapy.
@en
Novel targets for hepatitis B virus therapy.
@nl
P2860
P50
P356
P1433
P1476
Novel targets for hepatitis B virus therapy.
@en
P2093
Barbara Testoni
Fabien Zoulim
P2860
P356
10.1111/LIV.13307
P478
37 Suppl 1
P577
2017-01-01T00:00:00Z